Suppr超能文献

美哌隆是一种细胞色素P450 2D6催化的文拉法辛O-去甲基化的抑制剂。

Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.

作者信息

Grözinger M, Dragicevic A, Hiemke C, Shams M, Müller M J, Härtter S

机构信息

Department of Psychiatry, University of Mainz, Mainz, Germany.

出版信息

Pharmacopsychiatry. 2003 Jan;36(1):3-6. doi: 10.1055/s-2003-38084.

Abstract

INTRODUCTION

Melperone, a butyrophenone neuroleptic, is frequently used for its sleep-inducing properties. Despite its common use for more than 30 years, it is not yet characterized regarding its effects on cytochrome P450 s (CYPs). In an open pilot study, effects of melperone on the steady-state blood levels of venlafaxine, a recently introduced serotonin- and noradrenaline reuptake inhibiting antidepressant, were assessed.

METHODS

The dose-corrected serum concentrations of venlafaxine and O-desmethylvenlafaxine were analyzed retrospectively in a therapeutic drug-monitoring (TDM) database comprising 94 patients. In addition, three patients received venlafaxine and melperone concomitantly and the serum concentrations of venlafaxine and O-desmethylvenlafaxine were analyzed before, during, and after melperone co-medication. The effect of melperone on CYP2D6 was further assessed in seven patients by means of the dextromethorphan O-demethylation, which serves as a CYP2D6 probe reaction.

RESULTS

Patients treated concomitantly with venlafaxine and melperone had significantly higher (mean +/- SD) venlafaxine (3.27 +/- 2.9 vs. 0.97 +/- 0.99 ng/ml per mg/d; p < 0.05) and lower O-desmethylvenlafaxine serum concentrations (0.69 +/- 0.35 vs. 1.51 +/- 0.9 ng/ml per mg/d; p < 0.01) compared to patients without melperone comedication. In the three patients, venlafaxine serum concentrations increased, on average by 52 % during melperone co-medication, whereas O-desmethylvenlafaxine was decreased, on average by 29 %. Administration of melperone over three days elevated the ratio of dextromethorphan to dextrorphan from 0.044 +/- 0.04 to 0.09 +/- 0.083 (p < 0.05).

DISCUSSION

This study pointed to an inhibitory effect of melperone on the O-demethylation of venlafaxine. Because the O-demethylation of venlafaxine is almost exclusively catalyzed by CYP2D6 it is concluded that melperone is an inhibitor of CYP2D6. The hypothesis was further corroborated by the inhibitory effect of melperone on the dextromethorphan O-demethylation.

摘要

引言

美哌隆是一种丁酰苯类抗精神病药,常因其助眠特性而被使用。尽管其已广泛应用30多年,但关于其对细胞色素P450酶(CYPs)的影响尚无相关特征描述。在一项开放性预试验研究中,评估了美哌隆对文拉法辛稳态血药浓度的影响,文拉法辛是一种新上市的5-羟色胺和去甲肾上腺素再摄取抑制型抗抑郁药。

方法

在一个包含94例患者的治疗药物监测(TDM)数据库中,对文拉法辛和O-去甲基文拉法辛的剂量校正血清浓度进行回顾性分析。此外,3例患者同时服用文拉法辛和美哌隆,并在美哌隆联合用药前、用药期间和用药后分析文拉法辛和O-去甲基文拉法辛的血清浓度。通过右美沙芬O-去甲基化反应(作为CYP2D6探针反应)在7例患者中进一步评估美哌隆对CYP2D6的影响。

结果

与未联合使用美哌隆的患者相比,同时服用文拉法辛和美哌隆的患者文拉法辛(平均±标准差)显著更高(分别为3.27±2.9与0.97±0.99 ng/ml per mg/d;p<0.05),而O-去甲基文拉法辛血清浓度更低(分别为0.69±0.35与1.51±0.9 ng/ml per mg/d;p<0.01)。在这3例患者中,美哌隆联合用药期间文拉法辛血清浓度平均升高52%,而O-去甲基文拉法辛平均降低了29%。连续三天服用美哌隆使右美沙芬与右啡烷的比率从0.044±0.04升高至0.09±0.083(p<0.05)。

讨论

本研究表明美哌隆对文拉法辛的O-去甲基化有抑制作用。由于文拉法辛的O-去甲基化几乎完全由CYP2D6催化,因此得出结论美哌隆是CYP2D6的抑制剂。美哌隆对右美沙芬O-去甲基化的抑制作用进一步证实了这一假设。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验